Hester Biosciences News
- Market cap
- ₹1,750 crore
- P/E
- 22.5
- P/B
- 2.85
- ROE
- 14.5%
- Dividend yield
- 1.20%
- 52-week range
- ₹1,481.18 – ₹2,777.22
The latest update on Hester Biosciences is "Hester Biosciences Limited Reports Operational Performance & Quarterly Growth Update" (BSE Corporate Announcement), published 9 October 2026. This page lists 4 recent headlines and exchange announcements, 2 of them filed on BSE. Hester Biosciences' next board meeting for results is scheduled for 3 November 2026.
Latest Hester Biosciences news and announcements
Next results board meeting: 3 November 2026.
- Hester Biosciences Limited Reports Operational Performance & Quarterly Growth Update
- Market Activity: Hester Biosciences Limited Shares See Strong Institutional Volume
- Hester Biosciences Limited Board Compliances & Mandatory Disclosure Filings Submitted
- Analyst Review: Key Valuation Overview & Target Projection for Hester Biosciences Limited
Source: Publisher headlines and announcements filed on BSE, linked to their original sources. Data as of 9 October 2026. How this data is compiled.
Hester Biosciences news & announcements — frequently asked questions
What is the latest news on Hester Biosciences?
The most recent item is "Hester Biosciences Limited Reports Operational Performance & Quarterly Growth Update" from BSE Corporate Announcement on 9 October 2026. The full list above links to each original source.
When are Hester Biosciences' next results?
Hester Biosciences has announced a board meeting on 3 November 2026 to consider its financial results, according to its filing on BSE.
Where do these Hester Biosciences headlines come from?
Headlines link to the original publisher, and exchange announcements link to the filing on BSE. ATS lists them by date and does not rewrite or summarise them.
Same Data For Peers
Trade Hester Biosciences With ATS
Track HESTERBIO live and place orders from the Pocket app or the Pocket Web terminal with an ATS trading and demat account.
Figures are for information only and are not investment advice or a recommendation to buy, sell or hold any security. Investments in securities are subject to market risks; read all related documents carefully before investing.